MRI Publications

  1. Gunanathan C., Pais A., Furman-Haran E., Seger D., Eyal E., Mukhopadhyay S., Ben-David Y., Leitus G., Cohen H., Vilan A., Degani H. & Milstein D. (2007). Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging.  Bioconjugate Chemistry. 2007 Sept , 18 (5):1361-1365.
  2. Akselrod-Ballin A., Eyal E., Galun M., Furman-Haran E., Gomori J. M., Basri R., Degani H. & Brandt A. (2006). Automatic three-dimensional segmentation of MR images applied to the rat uterus - art. no. 61430R.  Medical Imaging 2006: Physiology, Function, And Structure From Medical Images Pts 1 And 2. 2006, 6143 :R1430-R1430.
  3. Dadiani M., Furman-Haran E. & Degani H. (2006). The application of NMR in tumor angiogenesis research.  Progress in Nuclear Magnetic Resonance Spectroscopy. 2006 Aug , 49 (1):27-44.
  4. Rosen Y., Ramniceanu G., Margalit R., Grobgeld D., Eilam R., Degani H. & Furman-Haran E. (2006). Vascular perfusion of human lung cancer in a rat orthotopic model using dynamic contrast-enhanced magnetic resonance imaging.  International Journal of Cancer. 2006 Jul , 119 (2):365-372.
  5. Hassid Y., Furman-Haran E., Margalit R., Eilam R. & Degani H. (2006). Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors.  Cancer Research. 2006 Apr , 66 (8):4159-+.
  6. Furman-Haran E., Schechtman E., Kelcz F., Kirshenbaum K. & Degani H. (2005). Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions.  Cancer. 2005 Aug , 104 (4):708-718.
  7. Degani H., Chetrit-Dadiani M., Bogin L. & Furman-Haran E. (2003). Magnetic resonance imaging of tumor vasculature.  Thrombosis and Haemostasis. 2003 Jan , 89 (1):25-33.
  8. Furman-Haran E. & Degani H. (2002). Parametric analysis of breast MRI.  Journal of Computer Assisted Tomography. 2002 May , 26 (3):376-386.
  9. Kelcz F., Furman-Haran E., Grobgeld D. & Degani H. (2002). Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast.  American Journal of Roentgenology. 2002 Dec , 179 (6):1485-1492.
  10. Furman-Haran E., Kelcz F. & Degani H. (2002). Magnetic resonance Imaging of breast cancer angiogenesis: A review.  Journal Of Experimental & Clinical Cancer Research. 2002 Sept , 21 (3):47-54.
  11. Furman-Haran E., Grobgeld D., Kelcz F. & Degani H. (2001). Critical role of spatial resolution in dynamic contrast-enhanced breast MRI.  Journal of Magnetic Resonance Imaging. 2001 Jun , 13 (6):862-867.
  12. Furman-Haran E., Grobgeld D., Margalit R. & Degani H. (1998). Response of MCF7 human breast cancer to tamoxifen: Evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method.  Clinical Cancer Research. 1998 Oct , 4 (10):2299-2304.
  13. Furman-Haran E., Margalit R., Grobgeld D. & Degani H. (1998). High resolution MRI of MCF7 human breast tumors: Complemented use of iron oxide microspheres and Gd-DTPA.  Jmri-Journal Of Magnetic Resonance Imaging. 1998 May , 8 (3):634-641.
  14. FurmanHaran E., Grobgeld D. & Degani H. (1997). Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors.  Journal of Magnetic Resonance. 1997 Oct , 128 (2):161-171.
  15. FurmanHaran E., Margalit R., Grobgeld D. & Degani H. (1996). Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors.  Proceedings of the National Academy of Sciences of the United States of America. 1996 Jun , 93 (13):6247-6251.
  16. FurmanHaran E., Margalit R., Maretzek A. & Degani H. (1996). Angiogenic response of MCF7 human breast cancer to hormonal treatment: Assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution.  Jmri-Journal Of Magnetic Resonance Imaging. 1996 Jan , 6 (1):195-202.